newsfilter
← Latest News
GlobeNewswire·

HilleVax to Participate in J.P. Morgan Biotech – 2022 Conference Call Series

BOSTON, Sept. 01, 2022 (GLOBE NEWSWIRE) -- HilleVax, Inc. (NASDAQ:HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it will participate in the J.P Morgan Biotech – 2022 Co